Overview of data collected in the CONCEPT cohort
Measurements | Instrument | Storage and analysis | |
Baseline 17 August 2015–6 July 2017 | Biological samples | ||
1 provider-collected cervical swab for: | |||
|
|
| |
|
| ||
| |||
1 provider-collected cervical swab for: | |||
|
|
| |
|
|
| |
|
| ||
| |||
Venous blood from index finger for: | |||
|
|
| |
Visual assessment | |||
|
|
| |
Anthropometric measures | |||
|
|
| |
| |||
Personal interview | |||
|
|
| |
| |||
| |||
|
| ||
14-month follow-up (first) 17 October 2016–6 October 2018 | Biological samples | ||
1 provider-collected cervical swab or self-collected swab for: | |||
|
|
| |
|
|
| |
|
| ||
Venous blood from index finger for: | |||
|
|
| |
| |||
Visual assessment | |||
|
|
| |
| |||
Personal interview | |||
|
|
| |
|
| ||
28-month follow-up (second) (17 December 2017–primo October 2020) | Biological samples | ||
1 provider-collected cervical swab or self-swab only for HPV positive women: |
|
| |
|
| ||
|
| ||
Venous blood from index finger for: | |||
|
| Same procedure as in first follow-up | |
Visual assessment | |||
|
|
| |
Personal interview | |||
|
|
| |
|
CONCEPT, Comprehensive Cervical Cancer Prevention in Tanzania; CTC, care and treatment clinics; HC2, hybrid caputure 2; HIV, human immunodeficiency virus; HPV, human papillomavirus; OUH, Odense University Hospital; VIA, visual inspection with acetic acid.